ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,361Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 663

$671K Total Retail Price of All Prescriptions

Rank: 29 out of 663

922 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 922 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

7% of this provider’s 922 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 8,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 491 454 1 3
SIMVASTATIN 370 336 2 1
LISINOPRIL 332 310 3 2
HYDROCODONE-ACETAMINOPHEN 220 175 S3 4 6
AMLODIPINE BESYLATE 215 212 5 5
OMEPRAZOLE 182 150 6 4
TRAMADOL HCL 181 153 7 17
WARFARIN SODIUM 168 145 8 8
ZOLPIDEM TARTRATE 165 131 9 16
ATORVASTATIN CALCIUM 163 160 10 13
METFORMIN HCL 160 139 11 9
FUROSEMIDE 151 128 12 7
ATENOLOL 149 143 13 10
CITALOPRAM HBR 136 118 14 18
TAMSULOSIN HCL 135 132 15 24
POTASSIUM CHLORIDE 114 90 16 23
HYDROCHLOROTHIAZIDE 110 110 17 12
LOVASTATIN 109 103 18 30
METOPROLOL TARTRATE 104 102 19 11
PANTOPRAZOLE SODIUM 99 94 20 45
LANTUS 97 68 21 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 68 22 22
FLUTICASONE PROPIONATE 92 84 23 27
ALENDRONATE SODIUM 91 89 24 15
LOSARTAN POTASSIUM 86 85 25 14
ZETIA 82 66 26 80
ALLOPURINOL 81 81 27 28
PREDNISONE 77 77 28 39
METOPROLOL SUCCINATE 77 66 28 25
GABAPENTIN 75 64 30 20
GEMFIBROZIL 75 57 30 109
AZITHROMYCIN 74 66 32 64
TRIAMTERENE-HCTZ 73 73 33 42
GLYBURIDE 71 58 R 34 83
OXYCODONE-ACETAMINOPHEN 68 47 S2 35 26
NAMENDA 67 61 36 57
TRAZODONE HCL 63 62 37 34
PROAIR HFA 61 43 38 33
SYNTHROID 61 35 38 46
DIOVAN 59 57 40 59
CYMBALTA 58 51 41 54
RANITIDINE HCL 55 52 42 31
SERTRALINE HCL 54 54 43 35
DONEPEZIL HCL 53 53 44 40
RAMIPRIL 53 53 44 132
NEXIUM 53 35 44 43
ATENOLOL-CHLORTHALIDONE 52 52 47 324
SPIRIVA 52 41 47 62
VENLAFAXINE HCL ER 51 51 49 86
CELEBREX 51 46 49 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.